Vanessa Bourgeaux

460 total citations
21 papers, 350 citations indexed

About

Vanessa Bourgeaux is a scholar working on Biotechnology, Molecular Biology and Physiology. According to data from OpenAlex, Vanessa Bourgeaux has authored 21 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biotechnology, 8 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Vanessa Bourgeaux's work include Cancer Research and Treatments (7 papers), Erythrocyte Function and Pathophysiology (5 papers) and Hemoglobinopathies and Related Disorders (4 papers). Vanessa Bourgeaux is often cited by papers focused on Cancer Research and Treatments (7 papers), Erythrocyte Function and Pathophysiology (5 papers) and Hemoglobinopathies and Related Disorders (4 papers). Vanessa Bourgeaux collaborates with scholars based in France, Austria and United Kingdom. Vanessa Bourgeaux's co-authors include Yann Godfrin, José M. Lanao, Bridget E. Bax, Friedrich Piller, Véronique Piller, Françoise Horand, Еlena Kosenko, Victor Vitvitsky, Elena I. Sinauridze and Oleksii Skorokhod and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Pharmaceutics.

In The Last Decade

Vanessa Bourgeaux

20 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Bourgeaux France 11 158 117 63 57 48 21 350
Rajwinder Dhami United States 11 298 1.9× 244 2.1× 11 0.2× 44 0.8× 28 0.6× 12 625
Serban San‐Marina Canada 9 224 1.4× 21 0.2× 13 0.2× 27 0.5× 23 0.5× 20 385
Kyle B. Matchett United Kingdom 14 243 1.5× 25 0.2× 42 0.7× 10 0.2× 11 0.2× 26 435
Tadahiro Hashita Japan 11 158 1.0× 33 0.3× 112 1.8× 9 0.2× 40 0.8× 33 399
Valentina Citro Italy 14 346 2.2× 123 1.1× 24 0.4× 81 1.4× 9 0.2× 25 494
Tomas Koltai Italy 10 225 1.4× 23 0.2× 69 1.1× 16 0.3× 23 0.5× 24 456
Amanda E. Brinker United States 11 207 1.3× 11 0.1× 39 0.6× 30 0.5× 18 0.4× 15 351
Nitin Puri United States 13 727 4.6× 31 0.3× 74 1.2× 31 0.5× 34 0.7× 22 895
Seymour Bakerman United States 11 140 0.9× 112 1.0× 28 0.4× 12 0.2× 21 0.4× 23 356
Karen Yang United States 9 192 1.2× 54 0.5× 61 1.0× 76 1.3× 15 0.3× 11 427

Countries citing papers authored by Vanessa Bourgeaux

Since Specialization
Citations

This map shows the geographic impact of Vanessa Bourgeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Bourgeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Bourgeaux more than expected).

Fields of papers citing papers by Vanessa Bourgeaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Bourgeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Bourgeaux. The network helps show where Vanessa Bourgeaux may publish in the future.

Co-authorship network of co-authors of Vanessa Bourgeaux

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Bourgeaux. A scholar is included among the top collaborators of Vanessa Bourgeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Bourgeaux. Vanessa Bourgeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Briançon, S., et al.. (2024). Are Nanostructured Lipid Carriers (NLC) better than Solid Lipid Nanoparticles (SLN) for delivering abiraterone acetate through the gastrointestinal tract?. International Journal of Pharmaceutics. 667(Pt B). 124869–124869. 3 indexed citations
3.
4.
Maubant, Sylvie, Marie Nathalie LeBlanc, Olivier Duchamp, et al.. (2019). Abstract 2258: Erymethionase (methionine-gamma-lyase encapsulated into red blood cells) potentiates anti-PD-1 therapy in TNBC syngeneic mouse model. Cancer Research. 79(13_Supplement). 2258–2258. 4 indexed citations
5.
Maubant, Sylvie, Olivier Duchamp, Fabrice Viviani, et al.. (2019). Abstract 2258: Erymethionase (methionine-gamma-lyase encapsulated into red blood cells) potentiates anti-PD-1 therapy in TNBC syngeneic mouse model. 2258–2258. 4 indexed citations
6.
Gay, Fabien, et al.. (2018). Abstract 5827: Enzymatic combination investigation in cancer therapy. Cancer Research. 78(13_Supplement). 5827–5827. 1 indexed citations
7.
Gay, Fabien, Willy Berlier, Delphine Maucort‐Boulch, et al.. (2017). Methionine tumor starvation by erythrocyte‐encapsulated methionine gamma‐lyase activity controlled with per os vitamin B6. Cancer Medicine. 6(6). 1437–1452. 34 indexed citations
8.
Bourgeaux, Vanessa, et al.. (2017). Methionine gamma-lyase-encapsulated into red blood cells (ERY-MET) antitumor activity in gastric carcinoma.. Journal of Clinical Oncology. 35(4_suppl). 78–78. 2 indexed citations
9.
Bourgeaux, Vanessa, José M. Lanao, Bridget E. Bax, & Yann Godfrin. (2016). Drug-loaded erythrocytes: on the road toward marketing approval. Drug Design Development and Therapy. 10. 665–665. 66 indexed citations
10.
Gay, Fabien, Philip L. Lorenzi, Vanessa Bourgeaux, et al.. (2016). Abstract 4812: Arginine deiminase loaded in erythrocytes: a promising formulation for L-arginine deprivation therapy in cancers. Cancer Research. 76(14_Supplement). 4812–4812. 7 indexed citations
11.
Gay, Fabien, et al.. (2015). Abstract 5330: Methioninase-loaded erythrocytes: a promising drug for L-methionine restriction therapy in cancer. Cancer Research. 75(15_Supplement). 5330–5330. 1 indexed citations
12.
Bourgeaux, Vanessa, Emmanuelle Canet‐Soulas, Vincent Pialoux, et al.. (2013). Hypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice. Clinical Hemorheology and Microcirculation. 54(3). 297–312. 19 indexed citations
13.
Lamarre, Yann, Vanessa Bourgeaux, Aurélien Pichon, et al.. (2012). Effect of inositol hexaphosphate–loaded red blood cells (RBCs) on the rheology of sickle RBCs. Transfusion. 53(3). 627–636. 10 indexed citations
14.
Bourgeaux, Vanessa, et al.. (2012). Efficacy of homologous inositol hexaphosphate‐loaded red blood cells in sickle transgenic mice. British Journal of Haematology. 157(3). 357–369. 17 indexed citations
15.
Bourgeaux, Vanessa, et al.. (2012). Evaluation of Analogues of GalNAc as Substrates for Enzymes of the Mammalian GalNAc Salvage Pathway. ACS Chemical Biology. 7(4). 753–760. 30 indexed citations
16.
Godfrin, Yann, Françoise Horand, Robert S. Franco, et al.. (2011). International seminar on the red blood cells as vehicles for drugs. Expert Opinion on Biological Therapy. 12(1). 127–133. 72 indexed citations
17.
Bourgeaux, Vanessa, et al.. (2010). Inositol hexaphosphate–loaded red blood cells prevent in vitro sickling. Transfusion. 50(10). 2176–2184. 16 indexed citations
18.
Bourgeaux, Vanessa, Martine Cadène, Friedrich Piller, & Véronique Piller. (2006). Efficient Enzymatic Glycosylation of Peptides and Oligosaccharides from GalNAc and UTP. ChemBioChem. 8(1). 37–40. 16 indexed citations
19.
Panday, Narendra, Jörg Benz, Denise Blum‐Kaelin, et al.. (2006). Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRα and β. Bioorganic & Medicinal Chemistry Letters. 16(19). 5231–5237. 10 indexed citations
20.
Bourgeaux, Vanessa, Friedrich Piller, & Véronique Piller. (2005). Two-step enzymatic synthesis of UDP-N-acetylgalactosamine. Bioorganic & Medicinal Chemistry Letters. 15(24). 5459–5462. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajwinder Dhami Breakdown of academic impact, for papers by Serban San‐Marina Breakdown of academic impact, for papers by Kyle B. Matchett Breakdown of academic impact, for papers by Tadahiro Hashita Breakdown of academic impact, for papers by Valentina Citro Breakdown of academic impact, for papers by Tomas Koltai Breakdown of academic impact, for papers by Amanda E. Brinker Breakdown of academic impact, for papers by Nitin Puri Breakdown of academic impact, for papers by Seymour Bakerman Breakdown of academic impact, for papers by Karen Yang
Rankless by CCL
2026